PT Indofarma Tbk (IDX:INAF)
Indonesia · Delayed Price · Currency is IDR 126.00
0.00 (0.00%)
At close: Jul 1, 2024
PT Indofarma Tbk Market Cap
PT Indofarma Tbk has a market cap or net worth of 390.51 billion as of February 9, 2026. Its market cap has decreased by -81.19% in one year.
Market Cap
390.51B
Enterprise Value
952.41B
Revenue
206.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
126.00
Market Cap Chart
Since April 18, 2001, PT Indofarma Tbk's market cap has increased from 328.00B to 390.51B, an increase of 19.06%. That is a compound annual growth rate of 0.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 390.51B | -78.28% |
| Dec 29, 2023 | 1.80T | -49.57% |
| Dec 30, 2022 | 3.56T | -48.43% |
| Dec 30, 2021 | 6.91T | -44.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 192.01T |
| PT Kalbe Farma Tbk. | 50.75T |
| PT Soho Global Health Tbk | 38.46T |
| PT Siloam International Hospitals Tbk | 36.88T |
| PT Itama Ranoraya Tbk | 609.16B |
| PT UBC Medical Indonesia Tbk | 556.95B |
| PT Diastika Biotekindo Tbk | 538.85B |
| PT Maja Agung Latexindo Tbk | 494.08B |